Guidance for the Clinical Trials Evaluation for Osteoarthritis

골관절염의 임상시험평가지침에 관한 연구

  • Na, Han-Sung (Clinical Research Division, Toxicological Evaluation and Research Department, National Institute Food and Drug Safety Evaluation) ;
  • Park, Hyun-Joo (Clinical Research Division, Toxicological Evaluation and Research Department, National Institute Food and Drug Safety Evaluation) ;
  • Oh, Woo-Yong (Oncology and Antibiotics Division, Korea Food and Drug Administration) ;
  • Han, Soon-Young (Clinical Research Division, Toxicological Evaluation and Research Department, National Institute Food and Drug Safety Evaluation) ;
  • Choi, Ki-Hwan (Cardiovascular and Neuropharmacology Drug Division, Korea Food and Drug Administration) ;
  • Wang, So-Young (Cardiovascular and Neuropharmacology Drug Division, Korea Food and Drug Administration) ;
  • Chung, Myeon-Woo (Clinical Research Division, Toxicological Evaluation and Research Department, National Institute Food and Drug Safety Evaluation)
  • 나한성 (식품의약품안전평가원 임상연구과) ;
  • 박현주 (식품의약품안전평가원 임상연구과) ;
  • 오우용 (식품의약품안전청 종양약품과) ;
  • 한순영 (식품의약품안전평가원 임상연구과) ;
  • 최기환 (식품의약품안전청 순환계약품과) ;
  • 왕소영 (식품의약품안전청 순환계약품과) ;
  • 정면우 (식품의약품안전평가원 임상연구과)
  • Received : 2009.10.14
  • Accepted : 2009.12.17
  • Published : 2009.12.30

Abstract

Keywords

References

  1. Altman R, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991;34(5):505-14 https://doi.org/10.1002/art.1780340502
  2. Altman R, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 1990;33(11):1601-10 https://doi.org/10.1002/art.1780331101
  3. Altman R, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29(8): 1039-49
  4. Harts AJ, et al. The association of obesity with joint pain and osteoarthritis in the HANES data. J Chronic Dis 1986;39(4): 1019-30
  5. Guidance for Industry : Clinical Development Programs for Drugs, Devices, and Biological Products Intended for the Treatment of Osteoarthritis (OA). FDA 1999. Available from: URL: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071577.pdf
  6. Points to Consider on Clinical Investigation of Medical Products Used in the Treatment of Osteoarthritis (OA). EMEA 1998
  7. Recommendations for the medical management of osteoarthritis of the hip and knee. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000;43:1905-1915. https://doi.org/10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P
  8. Boegard T, Josson K. Radiography in osteoarthritis of the knee. Skeletal Radiol 1999:28:605-615. https://doi.org/10.1007/s002560050561
  9. Clough JD. The Cleveland Clinic guide to Arthritis. New York: Kaplan Publishing, 2009:31-50.
  10. 김병성. 골관절염 : Korean J Fam Med. Vol. 30, No. 11 Suppl 2009
  11. Kellgren JH, Lawrence JS. Radiologic assessment of osteoarthrosis. Ann Rheum Dis 1957;16:494-502. https://doi.org/10.1136/ard.16.4.494